nach oben

Erschienen in:

25.11.2016 | Review

Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review

Erschienen in: Journal of Neurology | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

A growing body of the literature supports the use of magnetic resonance imaging as a potential biomarker for disease severity in the hereditary myopathies. We performed a systematic review of the medical literature to evaluate patterns of fat infiltration observed in magnetic resonance imaging studies of muscular dystrophy and congenital myopathy. Searches were performed using MEDLINE, EMBASE, and grey literature databases. Studies that described fat infiltration of muscles in patients with muscular dystrophy or congenital myopathy were selected for full-length review. Data on preferentially involved or spared muscles were extracted for analysis. A total of 2172 titles and abstracts were screened, and 70 publications met our criteria for inclusion in the systematic review. There were 23 distinct genetic disorders represented in this analysis. In most studies, preferential involvement and sparing of specific muscles were reported. We conclude that magnetic resonance imaging studies can be used to identify distinct patterns of muscle involvement in the hereditary myopathies. However, larger studies and standardized methods of reporting are needed to develop imaging as a diagnostic tool in these diseases.

Nur mit Berechtigung zugänglich

Murphy WA, Totty WG, Carroll JE (1986) MRI of normal and pathologic skeletal muscle. AJR Am J Roentgenol 146(3):565–574. doi:10.2214/ajr.146.3.565 CrossRefPubMed

Del Grande F, Carrino JA, Del Grande M, Mammen AL, Christopher Stine L (2011) Magnetic resonance imaging of inflammatory myopathies. Top Magn Reson Imaging TMRI 22(2):39–43. doi:10.1097/RMR.0b013e31825b2c35 CrossRefPubMed

Mercuri E, Pichiecchio A, Allsop J, Messina S, Pane M, Muntoni F (2007) Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging JMRI 25(2):433–440. doi:10.1002/jmri.20804 CrossRefPubMed

Wattjes MP, Kley RA, Fischer D (2010) Neuromuscular imaging in inherited muscle diseases. Eur Radiol 20(10):2447–2460. doi:10.1007/s00330-010-1799-2 CrossRefPubMedPubMedCentral

Tawil R, Padberg GW, Shaw DW, van der Maarel SM, Tapscott SJ, Participants FW (2016) Clinical trial preparedness in facioscapulohumeral muscular dystrophy: clinical, tissue, and imaging outcome measures 29–30 May 2015, Rochester, New York. Neuromuscul Disord NMD 26(2):181–186. doi:10.1016/j.nmd.2015.10.005 CrossRefPubMed

Higgins JPT, Green S (2008) Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions., Cochrane book seriesWiley-Blackwell, ChichesterCrossRef

Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62(10):1006–1012. doi:10.1016/j.jclinepi.2009.06.005 CrossRefPubMed

Faridian-Aragh N, Wagner KR, Leung DG, Carrino JA (2014) Magnetic resonance imaging phenotyping of Becker muscular dystrophy. Muscle Nerve 50(6):962–967. doi:10.1002/mus.24246 CrossRefPubMed

Tasca G, Iannaccone E, Monforte M, Masciullo M, Bianco F, Laschena F, Ottaviani P, Pelliccioni M, Pane M, Mercuri E, Ricci E (2012) Muscle MRI in Becker muscular dystrophy. Neuromuscul Disord NMD 22(Suppl 2):S100–S106. doi:10.1016/j.nmd.2012.05.015 CrossRefPubMed

10.

Loughran T, Higgins DM, McCallum M, Coombs A, Straub V, Hollingsworth KG (2015) Improving highly accelerated fat fraction measurements for clinical trials in muscular dystrophy: origin and quantitative effect of R2* changes. Radiology 275(2):570–578. doi:10.1148/radiol.14141191 CrossRefPubMed

11.

van den Bergen JC, Wokke BH, Janson AA, van Duinen SG, Hulsker MA, Ginjaar HB, van Deutekom JC, Aartsma-Rus A, Kan HE, Verschuuren JJ (2014) Dystrophin levels and clinical severity in Becker muscular dystrophy patients. J Neurol Neurosurg Psychiatry 85(7):747–753. doi:10.1136/jnnp-2013-306350 CrossRefPubMed

12.

Tasca G, Monforte M, Iannaccone E, Laschena F, Ottaviani P, Silvestri G, Masciullo M, Mirabella M, Servidei S, Ricci E (2012) Muscle MRI in female carriers of dystrophinopathy. Eur J Neurol 19(9):1256–1260. doi:10.1111/j.1468-1331.2012.03753.x CrossRefPubMed

13.

Kim HK, Laor T, Horn PS, Racadio JM, Wong B, Dardzinski BJ (2010) T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. Radiology 255(3):899–908. doi:10.1148/radiol.10091547 CrossRefPubMed

14.

Gaeta M, Messina S, Mileto A, Vita GL, Ascenti G, Vinci S, Bottari A, Vita G, Settineri N, Bruschetta D, Racchiusa S, Minutoli F (2012) Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments preliminary experience. Skelet Radiol 41(8):955–961CrossRef

15.

Kim HK, Merrow AC, Shiraj S, Wong BL, Horn PS, Laor T (2013) Analysis of fatty infiltration and inflammation of the pelvic and thigh muscles in boys with Duchenne muscular dystrophy (DMD): grading of disease involvement on MR imaging and correlation with clinical assessments. Pediatr Radiol 43(10):1327–1335. doi:10.1007/s00247-013-2696-z CrossRefPubMed

16.

Liu GC, Jong YJ, Chiang CH, Jaw TS (1993) Duchenne muscular dystrophy: MR grading system with functional correlation. Radiology 186(2):475–480. doi:10.1148/radiology.186.2.8421754 CrossRefPubMed

17.

Garrood P, Hollingsworth KG, Eagle M, Aribisala BS, Birchall D, Bushby K, Straub V (2009) MR imaging in Duchenne muscular dystrophy: quantification of T1-weighted signal, contrast uptake, and the effects of exercise. J Magn Reson Imaging JMRI 30(5):1130–1138. doi:10.1002/jmri.21941 CrossRefPubMed

18.

Li W, Zheng Y, Zhang W, Wang Z, Xiao J, Yuan Y (2015) Progression and variation of fatty infiltration of the thigh muscles in Duchenne muscular dystrophy, a muscle magnetic resonance imaging study. Neuromuscul Disord NMD 25(5):375–380. doi:10.1016/j.nmd.2015.01.003 CrossRefPubMed

19.

Ponrartana S, Ramos-Platt L, Wren TAL, Hu HH, Perkins TG, Chia JM, Gilsanz V (2014) Effectiveness of diffusion tensor imaging in assessing disease severity in Duchenne muscular dystrophy: preliminary study. Pediatr Radiol ((Ponrartana S., sponrartana@chla.usc.edu; Wren T.A.L.; Hu H.H.; Gilsanz V.) Department of Radiology, Children’s Hospital Los Angeles, Los Angeles, United States)

20.

Wokke BH, van den Bergen JC, Versluis MJ, Niks EH, Milles J, Webb AG, van Zwet EW, Aartsma-Rus A, Verschuuren JJ, Kan HE (2014) Quantitative MRI and strength measurements in the assessment of muscle quality in Duchenne muscular dystrophy. Neuromuscul Disord NMD 24(5):409–416. doi:10.1016/j.nmd.2014.01.015 CrossRefPubMed

21.

Kinali M, Arechavala-Gomeza V, Cirak S, Glover A, Guglieri M, Feng L, Hollingsworth KG, Hunt D, Jungbluth H, Roper HP, Quinlivan RM, Gosalakkal JA, Jayawant S, Nadeau A, Hughes-Carre L, Manzur AY, Mercuri E, Morgan JE, Straub V, Bushby K, Sewry C, Rutherford M, Muntoni F (2011) Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology 76(4):346–353. doi:10.1212/WNL.0b013e318208811f CrossRefPubMedPubMedCentral

22.

Torriani M, Townsend E, Thomas BJ, Bredella MA, Ghomi RH, Tseng BS (2012) Lower leg muscle involvement in Duchenne muscular dystrophy: an MR imaging and spectroscopy study. Skelet Radiol 41(4):437–445. doi:10.1007/s00256-011-1240-1 CrossRef

23.

Vohra RS, Lott D, Mathur S, Senesac C, Deol J, Germain S, Bendixen R, Forbes SC, Sweeney HL, Walter GA, Vandenborne K (2015) Magnetic resonance assessment of hypertrophic and pseudo-hypertrophic changes in lower leg muscles of boys with Duchenne muscular dystrophy and their relationship to functional measurements. PLoS One 10(6):e0128915. doi:10.1371/journal.pone.0128915 CrossRefPubMedPubMedCentral

24.

Ricotti V, Evans MR, Sinclair CD, Butler JW, Ridout DA, Hogrel JY, Emira A, Morrow JM, Reilly MM, Hanna MG, Janiczek RL, Matthews PM, Yousry TA, Muntoni F, Thornton JS (2016) Upper limb evaluation in Duchenne muscular dystrophy: fat-water quantification by mri, muscle force and function define endpoints for clinical trials. PLoS One 11(9):e0162542. doi:10.1371/journal.pone.0162542 CrossRefPubMedPubMedCentral

25.

Polavarapu K, Manjunath M, Preethish-Kumar V, Sekar D, Vengalil S, Thomas P, Sathyaprabha TN, Bharath RD, Nalini A (2016) Muscle MRI in Duchenne muscular dystrophy: evidence of a distinctive pattern. Neuromuscul Disord NMD. doi:10.1016/j.nmd.2016.09.002 PubMed

26.

Bing Q, Hu K, Tian Q, Zhao Z, Shen H, Li N, Hu J (2016) Semi-quantitative assessment of lower limb MRI in dystrophinopathy. Int J Clin Exp Med 9(7):13723–13732

27.

Godi C, Ambrosi A, Nicastro F, Previtali SC, Santarosa C, Napolitano S, Iadanza A, Scarlato M, Natali Sora MG, Tettamanti A, Gerevini S, Cicalese MP, Sitzia C, Venturini M, Falini A, Gatti R, Ciceri F, Cossu G, Torrente Y, Politi LS (2016) Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy. Ann Clin Transl Neurol 3(8):607–622CrossRefPubMedPubMedCentral

28.

Wokke BH, Van Den Bergen JC, Hooijmans MT, Verschuuren JJ, Niks EH, Kan HE (2016) T2 relaxation times are increased in Skeletal muscle of DMD but not BMD patients. Muscle Nerve 53(1):38–43CrossRefPubMed

29.

Fischer D, Hafner P, Rubino D, Schmid M, Neuhaus C, Jung H, Bieri O, Haas T, Gloor M, Fischmann A, Bonati U (2016) The 6-minute walk test, motor function measure and quantitative thigh muscle MRI in Becker muscular dystrophy: a cross-sectional study. Neuromuscul Disord 26(7):414–422CrossRefPubMed

30.

Tasca G, Monforte M, Iannaccone E, Laschena F, Ottaviani P, Leoncini E, Boccia S, Galluzzi G, Pelliccioni M, Masciullo M, Frusciante R, Mercuri E, Ricci E (2014) Upper girdle imaging in facioscapulohumeral muscular dystrophy. PLoS One 9(6):e100292. doi:10.1371/journal.pone.0100292 CrossRefPubMedPubMedCentral

31.

Jordan B, Eger K, Koesling S, Zierz S (2011) Camptocormia phenotype of FSHD: a clinical and MRI study on six patients. J Neurol 258(5):866–873. doi:10.1007/s00415-010-5858-z CrossRefPubMed

32.

Regula JU, Jestaedt L, Jende F, Bartsch A, Meinck HM, Weber MA (2015) Clinical muscle testing compared with whole-body magnetic resonance imaging in facio-scapulo-humeral muscular dystrophy. Clin Neuroradiol. doi:10.1007/s00062-015-0386-y PubMed

33.

Gerevini S, Scarlato M, Maggi L, Cava M, Caliendo G, Pasanisi B, Falini A, Previtali SC, Morandi L (2015) Muscle MRI findings in facioscapulohumeral muscular dystrophy. Eur Radiol ((Gerevini S., simonetta.gerevini@hsr.it; Caliendo G.; Falini A.) Neuroradiology Unit, Head and Neck Department, IRCCS San Raffaele Scientific Institute, Milan, Italy)

34.

Leung DG, Carrino JA, Wagner KR, Jacobs MA (2015) Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy. Muscle Nerve 52(4):512–520. doi:10.1002/mus.24569 CrossRefPubMedPubMedCentral

35.

Rijken NH, van Engelen BG, de Rooy JW, Geurts AC, Weerdesteyn V (2014) Trunk muscle involvement is most critical for the loss of balance control in patients with facioscapulohumeral muscular dystrophy. Clin Biomech (Bristol, Avon) 29(8):855–860. doi:10.1016/j.cl0inbiomech.2014.07.008 CrossRef

36.

Olsen DB, Gideon P, Jeppesen TD, Vissing J (2006) Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI. J Neurol 253(11):1437–1441. doi:10.1007/s00415-006-0230-z CrossRefPubMed

37.

Iosa M, Mazza C, Frusciante R, Zok M, Aprile I, Ricci E, Cappozzo A (2007) Mobility assessment of patients with facioscapulohumeral dystrophy. Clin Biomech (Bristol, Avon) 22(10):1074–1082. doi:10.1016/j.clinbiomech.2007.07.013 CrossRef

38.

Tasca G, Monforte M, Ottaviani P, Pelliccioni M, Frusciante R, Laschena F, Ricci E (2016) Magnetic Resonance Imaging in a large cohort of facioscapulohumeral muscular dystrophy patients: pattern refinement and implications for clinical trials. Ann Neurol. doi:10.1002/ana.24640 PubMed

39.

Janssen BH, Voet NB, Nabuurs CI, Kan HE, de Rooy JW, Geurts AC, Padberg GW, van Engelen BG, Heerschap A (2014) Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration. PLoS One 9(1):e85416. doi:10.1371/journal.pone.0085416 CrossRefPubMedPubMedCentral

40.

Lareau-Trudel E, Troter AL, Ghattas B, Pouget J, Attarian S, Bendahan D, Salort-Campana E (2015) Muscle quantitative MR imaging and clustering analysis in patients with facioscapulohumeral muscular dystrophy type 1. PLoS One 10(7): e0132717. doi:10.1371/journal.pone.0132717

41.

Kan HE, Klomp DW, Wohlgemuth M, van Loosbroek-Wagemans I, van Engelen BG, Padberg GW, Heerschap A (2010) Only fat infiltrated muscles in resting lower leg of FSHD patients show disturbed energy metabolism. NMR Biomed 23(6):563–568. doi:10.1002/nbm.1494 CrossRefPubMed

42.

Friedman SD, Poliachik SL, Carter GT, Budech CB, Bird TD, Shaw DW (2012) The magnetic resonance imaging spectrum of facioscapulohumeral muscular dystrophy. Muscle Nerve 45(4):500–506. doi:10.1002/mus.22342 CrossRefPubMed

43.

Janssen B, Voet N, Geurts A, Van Engelen B, Heerschap A (2016) Quantitative MRI reveals decelerated fatty infiltration in muscles of active FSHD patients. Neurology 86(18):1700–1707CrossRefPubMed

44.

45.

Fischer D, Walter MC, Kesper K, Petersen JA, Aurino S, Nigro V, Kubisch C, Meindl T, Lochmuller H, Wilhelm K, Urbach H, Schroder R (2005) Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs. J Neurol 252(5):538–547. doi:10.1007/s00415-005-0684-4 CrossRefPubMed

46.

Mercuri E, Bushby K, Ricci E, Birchall D, Pane M, Kinali M, Allsop J, Nigro V, Saenz A, Nascimbeni A, Fulizio L, Angelini C, Muntoni F (2005) Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures. Neuromuscul Disord NMD 15(2):164–171. doi:10.1016/j.nmd.2004.10.008 CrossRefPubMed

47.

Kesper K, Kornblum C, Reimann J, Lutterbey G, Schroder R, Wattjes MP (2009) Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study. Acta Neurol Scand 120(2):111–118. doi:10.1111/j.1600-0404.2008.01129.x CrossRefPubMed

48.

Diaz J, Woudt L, Suazo L, Garrido C, Caviedes P, Cardenas AM, Castiglioni C, Bevilacqua JA (2016) Broadening the imaging phenotype of dysferlinopathy at different disease stages. Muscle Nerve. doi:10.1002/mus.25045 PubMed

49.

Paradas C, Llauger J, Diaz-Manera J, Rojas-Garcia R, De Luna N, Iturriaga C, Marquez C, Uson M, Hankiewicz K, Gallardo E, Illa I (2010) Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies. Neurology 75(4):316–323. doi:10.1212/WNL.0b013e3181ea1564 CrossRefPubMed

50.

Degardin A, Morillon D, Lacour A, Cotten A, Vermersch P, Stojkovic T (2010) Morphologic imaging in muscular dystrophies and inflammatory myopathies. Skelet Radiol 39(12):1219–1227. doi:10.1007/s00256-010-0930-4 CrossRef

51.

Willis TA, Hollingsworth KG, Coombs A, Sveen ML, Andersen S, Stojkovic T, Eagle M, Mayhew A, de Sousa PL, Dewar L, Morrow JM, Sinclair CD, Thornton JS, Bushby K, Lochmuller H, Hanna MG, Hogrel JY, Carlier PG, Vissing J, Straub V (2014) Quantitative magnetic resonance imaging in limb-girdle muscular dystrophy 2I: a multinational cross-sectional study. PLoS One 9(2):e90377. doi:10.1371/journal.pone.0090377 CrossRefPubMedPubMedCentral

52.

Mahjneh I, Bashir R, Kiuru-Enari S, Linssen W, Lamminen A, Visser M (2012) Selective pattern of muscle involvement seen in distal muscular dystrophy associated with anoctamin 5 mutations: a follow-up muscle MRI study. Neuromuscul Disord NMD 22(Suppl 2):S130–S136. doi:10.1016/j.nmd.2012.02.007 CrossRefPubMed

53.

Sarkozy A, Deschauer M, Carlier RY, Schrank B, Seeger J, Walter MC, Schoser B, Reilich P, Leturq F, Radunovic A, Behin A, Laforet P, Eymard B, Schreiber H, Hicks D, Vaidya SS, Glaser D, Carlier PG, Bushby K, Lochmuller H, Straub V (2012) Muscle MRI findings in limb girdle muscular dystrophy type 2L. Neuromuscul Disord NMD 22(Suppl 2):S122–S129. doi:10.1016/j.nmd.2012.05.012 CrossRefPubMed

54.

Jin SQ, Yu M, Zhang W, Lyu H, Yuan Y, Wang ZX (2016) Dysferlin gene mutation spectrum in a large cohort of chinese patients with dysferlinopathy. Chin Med J (Engl) 129(19):2287–2293. doi:10.4103/0366-6999.190671 CrossRef

55.

Mercuri E, Lampe A, Allsop J, Knight R, Pane M, Kinali M, Bonnemann C, Flanigan K, Lapini I, Bushby K, Pepe G, Muntoni F (2005) Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy. Neuromuscul Disord NMD 15(4):303–310. doi:10.1016/j.nmd.2005.01.004 CrossRefPubMed

56.

Quijano-Roy S, Avila-Smirnow D, Carlier RY, group W-Mms (2012) Whole body muscle MRI protocol: pattern recognition in early onset NM disorders. Neuromuscul Disord NMD 22(Suppl 2):S68–S84. doi:10.1016/j.nmd.2012.08.003 CrossRefPubMed

57.

Mercuri E, Cini C, Pichiecchio A, Allsop J, Counsell S, Zolkipli Z, Messina S, Kinali M, Brown SC, Jimenez C, Brockington M, Yuva Y, Sewry CA, Muntoni F (2003) Muscle magnetic resonance imaging in patients with congenital muscular dystrophy and Ullrich phenotype. Neuromuscul Disord NMD 13(7–8):554–558CrossRefPubMed

58.

Gomez-Andres D, Dabaj I, Mompoint D, Hankiewicz K, Azzi V, Ioos C, Romero NB, Ben Yaou R, Bergounioux J, Bonne G, Richard P, Estournet B, Yves-Carlier R, Quijano-Roy S (2015) Pediatric laminopathies: whole-body MRI fingerprint and comparison with SEPN1-myopathy. Muscle Nerve. doi:10.1002/mus.25018 PubMed

59.

Mercuri E, Counsell S, Allsop J, Jungbluth H, Kinali M, Bonne G, Schwartz K, Bydder G, Dubowitz V, Muntoni F (2002) Selective muscle involvement on magnetic resonance imaging in autosomal dominant Emery–Dreifuss muscular dystrophy. Neuropediatrics 33(1):10–14. doi:10.1055/s-2002-23593 CrossRefPubMed

60.

Carboni N, Mura M, Marrosu G, Cocco E, Marini S, Solla E, Mateddu A, Maioli MA, Piras R, Mallarini G, Mercuro G, Porcu M, Marrosu MG (2010) Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations. Muscle Nerve 41(4):458–463. doi:10.1002/mus.21514 CrossRefPubMed

61.

Hankiewicz K, Carlier RY, Lazaro L, Linzoain J, Barnerias C, Gomez-Andres D, Avila-Smirnow D, Ferreiro A, Estournet B, Guicheney P, Germain DP, Richard P, Bulacio S, Mompoint D, Quijano-Roy S (2015) Whole-body muscle magnetic resonance imaging in SEPN1-related myopathy shows a homogeneous and recognizable pattern. Muscle Nerve 52(5):728–735. doi:10.1002/mus.24634 CrossRefPubMed

62.

Jungbluth H, Davis MR, Muller C, Counsell S, Allsop J, Chattopadhyay A, Messina S, Mercuri E, Laing NG, Sewry CA, Bydder G, Muntoni F (2004) Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations. Neuromuscul Disord NMD 14(12):785–790. doi:10.1016/j.nmd.2004.08.006 CrossRefPubMed

63.

Jarraya M, Quijano-Roy S, Monnier N, Behin A, Avila-Smirnov D, Romero NB, Allamand V, Richard P, Barois A, May A, Estournet B, Mercuri E, Carlier PG, Carlier RY (2012) Whole-Body muscle MRI in a series of patients with congenital myopathy related to TPM2 gene mutations. Neuromuscul Disord NMD 22(Suppl 2):S137–S147. doi:10.1016/j.nmd.2012.06.347 CrossRefPubMed

64.

Jungbluth H, Sewry CA, Counsell S, Allsop J, Chattopadhyay A, Mercuri E, North K, Laing N, Bydder G, Pelin K, Wallgren-Pettersson C, Muntoni F (2004) Magnetic resonance imaging of muscle in nemaline myopathy. Neuromuscul Disord NMD 14(12):779–784. doi:10.1016/j.nmd.2004.08.005 CrossRefPubMed

65.

Schramm N, Born C, Weckbach S, Reilich P, Walter MC, Reiser MF (2008) Involvement patterns in myotilinopathy and desminopathy detected by a novel neuromuscular whole-body MRI protocol. Eur Radiol 18(12):2922–2936. doi:10.1007/s00330-008-1071-1 CrossRefPubMed

66.

McNeill A, Birchall D, Straub V, Goldfarb L, Reilich P, Walter MC, Schramm N, Lochmuller H, Chinnery PF (2009) Lower limb radiology of distal myopathy due to the S60F myotilin mutation. Eur Neurol 62(3):161–166. doi:10.1159/000227266 CrossRefPubMedPubMedCentral

67.

Muller TJ, Kraya T, Stoltenburg-Didinger G, Hanisch F, Kornhuber M, Stoevesandt D, Senderek J, Weis J, Baum P, Deschauer M, Zierz S (2014) Phenotype of matrin-3-related distal myopathy in 16 German patients. Ann Neurol 76(5):669–680. doi:10.1002/ana.24255 CrossRefPubMed

68.

Mahjneh I, Lamminen AE, Udd B, Paetau AE, Hackman P, Korhola OA, Somer HV (2004) Muscle magnetic resonance imaging shows distinct diagnostic patterns in Welander and tibial muscular dystrophy. Acta Neurol Scand 110(2):87–93. doi:10.1111/j.1600-0404.2004.00283.x CrossRefPubMed

69.

Fischmann A, Gloor M, Fasler S, Haas T, Rodoni Wetzel R, Bieri O, Wetzel S, Heinimann K, Scheffler K, Fischer D (2011) Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy. J Neurol 258(7):1333–1340. doi:10.1007/s00415-011-5937-9 CrossRefPubMed

70.

Zhao J, Liu J, Xiao J, Du J, Que C, Shi X, Liang W, Sun W, Zhang W, Lv H, Yuan Y, Wang Z (2015) Clinical and muscle imaging findings in 14 mainland chinese patients with oculopharyngodistal myopathy. PLoS One 10(6):e0128629. doi:10.1371/journal.pone.0128629 CrossRefPubMedPubMedCentral

71.

Fu J, Zheng YM, Jin SQ, Yi JF, Liu XJ, Lyn H, Wang ZX, Zhang W, Xiao JX, Yuan Y (2016) “Target” and “sandwich” signs in thigh muscles have high diagnostic values for collagen VI-related myopathies. Chin Med J 129(15):1811–1816CrossRefPubMedPubMedCentral

72.

Fiorillo C, Astrea G, Savarese M, Cassandrini D, Brisca G, Trucco F, Pedemonte M, Trovato R, Ruggiero L, Vercelli L, D’Amico A, Tasca G, Pane M, Fanin M, Bello L, Broda P, Musumeci O, Rodolico C, Messina S, Vita GL, Sframeli M, Gibertini S, Morandi L, Mora M, Maggi L, Petrucci A, Massa R, Grandis M, Toscano A, Pegoraro E, Mercuri E, Bertini E, Mongini T, Santoro L, Nigro V, Minetti C, Santorelli FM, Bruno C (2016) MYH7-related myopathies: clinical, histopathological and imaging findings in a cohort of Italian patients. Orphanet J Rare Dis 11(1):91. doi:10.1186/s13023-016-0476-1 CrossRefPubMedPubMedCentral

73.

Sugie K, Sugie M, Taoka T, Tonomura Y, Kumazawa A, Izumi T, Kichikawa K, Ueno S (2015) Characteristic MRI findings of upper limb muscle involvement in myotonic dystrophy type 1. PLoS One 10(4):e0125051. doi:10.1371/journal.pone.0125051 CrossRefPubMedPubMedCentral

74.

Kornblum C, Lutterbey G, Bogdanow M, Kesper K, Schild H, Schroder R, Wattjes MP (2006) Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2: a whole body highfield MRI study. J Neurol 253(6):753–761. doi:10.1007/s00415-006-0111-5 CrossRefPubMed

75.

Damian MS, Bachmann G, Herrmann D, Dorndorf W (1993) Magnetic resonance imaging of muscle and brain in myotonic dystrophy. J Neurol 240(1):8–12CrossRefPubMed

76.

Hamano T, Kawamura Y, Mutoh T, Hirayama M, Kuriyama M (2010) Muscle MRI in myotonic dystrophy type 1 with foot drop. Eur Neurol 63(3):144–148. doi:10.1159/000280763 CrossRefPubMed

77.

Hayashi K, Hamano T, Kawamura Y, Kimura H, Matsunaga A, Ikawa M, Yamamura O, Mutoh T, Higuchi I, Kuriyama M, Nakamoto Y (2016) Muscle MRI of the upper extremity in the myotonic dystrophy type 1. Eur Neurol 76(1–2):87–94CrossRefPubMed

78.

Mercuri E, Talim B, Moghadaszadeh B, Petit N, Brockington M, Counsell S, Guicheney P, Muntoni F, Merlini L (2002) Clinical and imaging findings in six cases of congenital muscular dystrophy with rigid spine syndrome linked to chromosome 1p (RSMD1). Neuromuscul Disord NMD 12(7–8):631–638CrossRefPubMed

79.

Lamminen AE (1990) Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement. Br J Radiol 63(756):946–950. doi:10.1259/0007-1285-63-756-946 CrossRefPubMed

80.

Stramare R, Beltrame V, Dal Borgo R, Gallimberti L, Frigo AC, Pegoraro E, Angelini C, Rubaltelli L, Feltrin GP (2010) MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. Radiologia Medica ((Stramare R., roberto.stramare@unipd.it; Beltrame V.; Dal Borgo R.; Gallimberti L.; Rubaltelli L.; Feltrin G.P.) Department of Medical Diagnostic Sciences and Special Therapies, University of Padova, Padova, 35128, Italy):1–15

81.

Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, Flanigan KM, Pestronk A, Tawil R, Wolfe GI, Eagle M, Florence JM, King WM, Pandya S, Straub V, Juneau P, Meyers K, Csimma C, Araujo T, Allen R, Parsons SA, Wozney JM, Lavallie ER, Mendell JR (2008) A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 63(5):561–571. doi:10.1002/ana.21338 CrossRefPubMed

82.

Campbell C, McMillan HJ, Mah JK, Tarnopolsky M, Selby K, McClure T, Wilson DM, Sherman ML, Escolar D, Attie KM (2016) Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: results of a randomized, placebo-controlled clinical trial. Muscle Nerve. doi:10.1002/mus.25268

83.

Sakellariou P, Kekou K, Fryssira H, Sofocleous C, Manta P, Panousopoulou A, Gounaris K, Kanavakis E (2012) Mutation spectrum and phenotypic manifestation in FSHD Greek patients. Neuromuscul Disord NMD 22(4):339–349. doi:10.1016/j.nmd.2011.11.001 CrossRefPubMed

84.

Lin F, Wang ZQ, Lin MT, Murong SX, Wang N (2015) New Insights into genotype-phenotype correlations in Chinese facioscapulohumeral muscular dystrophy: a retrospective analysis of 178 patients. Chin Med J (Engl) 128(13):1707–1713. doi:10.4103/0366-6999.159336 CrossRef

85.

ten Dam L, van der Kooi AJ, van Wattingen M, de Haan RJ, de Visser M (2012) Reliability and accuracy of skeletal muscle imaging in limb-girdle muscular dystrophies. Neurology 79(16):1716–1723. doi:10.1212/WNL.0b013e31826e9b73 CrossRefPubMed

86.

Díaz-Manera J, Alejaldre A, González L, Olivé M, Gómez-Andrés D, Muelas N, Vílchez JJ, Llauger J, Carbonell P, Márquez-Infante C, Fernández-Torrón R, Poza JJ, López de Munáin A, González-Quereda L, Mirabet S, Clarimon J, Gallano P, Rojas-García R, Gallardo E, Illa I (2016) Muscle imaging in muscle dystrophies produced by mutations in the EMD and LMNA genes. Neuromuscul Disord 26(1):33–40CrossRefPubMed

87.

Morrow JM, Matthews E, Raja Rayan DL, Fischmann A, Sinclair CD, Reilly MM, Thornton JS, Hanna MG, Yousry TA (2013) Muscle MRI reveals distinct abnormalities in genetically proven non-dystrophic myotonias. Neuromuscul Disord NMD 23(8):637–646. doi:10.1016/j.nmd.2013.05.001 CrossRefPubMed

88.

Kornblum C, Lutterbey GG, Czermin B, Reimann J, von Kleist-Retzow JC, Jurkat-Rott K, Wattjes MP (2010) Whole-body high-field MRI shows no skeletal muscle degeneration in young patients with recessive myotonia congenita. Acta Neurol Scand 121(2):131–135. doi:10.1111/j.1600-0404.2009.01228.x CrossRefPubMed

89.

Horvath JJ, Austin SL, Case LE, Greene KB, Jones HN, Soher BJ, Kishnani PS, Bashir MR (2015) Correlation between quantitative whole-body muscle magnetic resonance imaging and clinical muscle weakness in Pompe disease. Muscle Nerve 51(5):722–730. doi:10.1002/mus.24437 CrossRefPubMed

90.

Olsen DB, Langkilde AR, Orngreen MC, Rostrup E, Schwartz M, Vissing J (2003) Muscle structural changes in mitochondrial myopathy relate to genotype. J Neurol 250(11):1328–1334. doi:10.1007/s00415-003-0206-1 CrossRefPubMed

91.

Hollingsworth KG, de Sousa PL, Straub V, Carlier PG (2012) Towards harmonization of protocols for MRI outcome measures in skeletal muscle studies: consensus recommendations from two TREAT-NMD NMR workshops, 2 May 2010, Stockholm, Sweden, 1–2 October 2009, Paris, France. Neuromuscul Disord NMD 22(Suppl 2):S54–S67. doi:10.1016/j.nmd.2012.06.005 CrossRefPubMed

Titel: Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review
Publikationsdatum: 25.11.2016
Erschienen in: Journal of Neurology / Ausgabe 7/2017
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-016-8350-6

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2017

Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study

Lateralized microstructural changes in early-stage Parkinson’s disease in anterior olfactory structures, but not in substantia nigra

Erratum to: Plasma exchange response in 34 patients with severe optic neuritis

Erratum to: Muscle MRI in neutral lipid storage disease (NLSD)

A multi-source approach to determine SMA incidence and research ready population

Comparative effectiveness of eight antiepileptic drugs in adults with focal refractory epilepsy: the influence of age, gender, and the sequence in which drugs were introduced onto the market

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie